75 related articles for article (PubMed ID: 27383253)
1. siRNA targeting the κ light chain constant region: preclinical testing of an approach to nonfibrillar and fibrillar light chain deposition diseases.
Ma X; Zhou P; Wong SW; Warner M; Chaulagain C; Comenzo RL
Gene Ther; 2016 Oct; 23(10):727-733. PubMed ID: 27383253
[TBL] [Abstract][Full Text] [Related]
2. A novel xenograft mouse model for testing approaches targeting human kappa light-chain diseases.
Ma X; Zhou P; Kugelmass A; Toskic D; Warner M; Lee L; Fogaren T; Godara A; Wang M; Li Y; Yang L; Xu Q; Comenzo RL
Gene Ther; 2019 May; 26(5):187-197. PubMed ID: 30926963
[TBL] [Abstract][Full Text] [Related]
3. Both the environment and somatic mutations govern the aggregation pathway of pathogenic immunoglobulin light chain.
Davis DP; Gallo G; Vogen SM; Dul JL; Sciarretta KL; Kumar A; Raffen R; Stevens FJ; Argon Y
J Mol Biol; 2001 Nov; 313(5):1021-34. PubMed ID: 11700059
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin light-chain toxicity in a mouse model of monoclonal immunoglobulin light-chain deposition disease.
Bender S; Ayala MV; Bonaud A; Javaugue V; Carrion C; Oblet C; Rinsant A; Kaaki S; Oruc Z; Boyer F; Paquet A; Pons N; Hervé B; Ashi MO; Jaccard A; Delpy L; Touchard G; Cogné M; Bridoux F; Sirac C
Blood; 2020 Oct; 136(14):1645-1656. PubMed ID: 32559766
[TBL] [Abstract][Full Text] [Related]
5. Chimeric immunoglobulin light chains are secreted at different levels: influence of framework-1 amino acids.
Horwitz AH; Nadell R; Preugschat F; Better M
Mol Immunol; 1994 Jun; 31(9):683-92. PubMed ID: 8028603
[TBL] [Abstract][Full Text] [Related]
6. Primary structure of a variable region of the V kappa I subgroup (ISE) in light chain deposition disease.
Rocca A; Khamlichi AA; Aucouturier P; Noël LH; Denoroy L; Preud'homme JL; Cogné M
Clin Exp Immunol; 1993 Mar; 91(3):506-9. PubMed ID: 7680298
[TBL] [Abstract][Full Text] [Related]
7. Preclinical development of siRNA therapeutics for AL amyloidosis.
Hovey BM; Ward JE; Soo Hoo P; O'Hara CJ; Connors LH; Seldin DC
Gene Ther; 2011 Dec; 18(12):1150-6. PubMed ID: 21562591
[TBL] [Abstract][Full Text] [Related]
8. Structure of a monoclonal kappa chain of the V kappa IV subgroup in the kidney and plasma cells in light chain deposition disease.
Cogné M; Preud'homme JL; Bauwens M; Touchard G; Aucouturier P
J Clin Invest; 1991 Jun; 87(6):2186-90. PubMed ID: 1904072
[TBL] [Abstract][Full Text] [Related]
9. One siRNA pool targeting the λ constant region stops λ light-chain production and causes terminal endoplasmic reticulum stress.
Zhou P; Ma X; Iyer L; Chaulagain C; Comenzo RL
Blood; 2014 May; 123(22):3440-51. PubMed ID: 24723680
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of the murine lupus-associated anti-self response: involvement of a large number of heavy and light chain variable region genes.
Kofler R; Noonan DJ; Strohal R; Balderas RS; Møller NP; Dixon FJ; Theofilopoulos AN
Eur J Immunol; 1987 Jan; 17(1):91-5. PubMed ID: 3102255
[TBL] [Abstract][Full Text] [Related]
11. Limited junctional diversity in kappa light chains. Junctional sequences from CD43+B220+ early B cell progenitors resemble those from peripheral B cells.
Victor KD; Vu K; Feeney AJ
J Immunol; 1994 Apr; 152(7):3467-75. PubMed ID: 7511648
[TBL] [Abstract][Full Text] [Related]
12. Structure of a germline rabbit immunoglobulin V kappa-region gene: implications for rabbit V kappa-J kappa recombination.
Lieberman R; Emorine L; Max EE
J Immunol; 1984 Nov; 133(5):2753-6. PubMed ID: 6434636
[TBL] [Abstract][Full Text] [Related]
13. Analysis of heavy and light chain sequences of conventional camelid antibodies from Camelus dromedarius and Camelus bactrianus species.
Griffin LM; Snowden JR; Lawson AD; Wernery U; Kinne J; Baker TS
J Immunol Methods; 2014 Mar; 405():35-46. PubMed ID: 24444705
[TBL] [Abstract][Full Text] [Related]
14. The importance of the light chain for the epitope specificity of human anti-U1 small nuclear RNA autoantibodies present in systemic lupus erythematosus patients.
Hoet RM; Pieffers M; Stassen MH; Raats J; de Wildt R; Pruijn GJ; van den Hoogen F; van Venrooij WJ
J Immunol; 1999 Sep; 163(6):3304-12. PubMed ID: 10477600
[TBL] [Abstract][Full Text] [Related]
15. Variegated transcriptional activation of the immunoglobulin kappa locus in pre-b cells contributes to the allelic exclusion of light-chain expression.
Liang HE; Hsu LY; Cado D; Schlissel MS
Cell; 2004 Jul; 118(1):19-29. PubMed ID: 15242641
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of pathologic immunoglobulin-free light chain production by small interfering RNA molecules.
Phipps JE; Kestler DP; Foster JS; Kennel SJ; Donnell R; Weiss DT; Solomon A; Wall JS
Exp Hematol; 2010 Nov; 38(11):1006-13. PubMed ID: 20637260
[TBL] [Abstract][Full Text] [Related]
17. [Hepatic and renal deposits of kappa light chains revealing a dysglobulinemia (author's transl)].
Mignon F; Morel-Maroger L; Cerf M; Preud'homme JL; Richet G
Nephrologie; 1980; 1(4):167-70. PubMed ID: 6795518
[TBL] [Abstract][Full Text] [Related]
18. Kappa-type light chain crystal storage histiocytosis.
Terashima K; Takahashi K; Kojima M; Imai Y; Tsuchida S; Migita S; Ebina S; Itoh C
Acta Pathol Jpn; 1978 Jan; 28(1):111-38. PubMed ID: 416650
[TBL] [Abstract][Full Text] [Related]
19. Separating antibody species containing one and two kappa light chain constant region by KappaSelect affinity chromatography.
Qin T; Wang Y; Li Y
Protein Expr Purif; 2020 Jul; 171():105618. PubMed ID: 32151654
[TBL] [Abstract][Full Text] [Related]
20. Basolateral secretion of kappa light chain in the polarised epithelial cell line, Caco-2.
Hughson EJ; Cutler DF; Hopkins CR
J Cell Sci; 1989 Oct; 94 ( Pt 2)():327-32. PubMed ID: 2516089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
